Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
5,26 USD | -0,94% | -1,31% | -22,53% |
Attività
Numero di dipendenti: 107
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Biologics and Drug Delivery - Services and License
47,8
%
| 5 | 26,4 % | 11 | 47,8 % | +110,83% |
Functional Neurosurgery Navigation and Therapy - Disposable Products
31,7
%
| 8 | 36,9 % | 8 | 31,7 % | +0,03% |
Biologics and Drug Delivery - Disposable Products
9,0
%
| 4 | 18,0 % | 2 | 9,0 % | -41,63% |
Capital Equipment and Software - Services
4,1
%
| 1 | 3,9 % | 1 | 4,1 % | +22,39% |
Functional Neurosurgery Navigation and Therapy - Services
3,9
%
| 2 | 7,5 % | 1 | 3,9 % | -39,43% |
Capital Equipment and Software - Systems and Software Products
3,6
%
| 2 | 7,4 % | 1 | 3,6 % | -43,12% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 21 | 100,0 % | 24 | 100,0 % | +16,56% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Joseph Burnett
CEO | Chief Executive Officer | 47 | 07/11/17 |
Director of Finance/CFO | 39 | 29/09/20 | |
Mazin Sabra
COO | Chief Operating Officer | 44 | 10/10/22 |
Caroline Corner
IRC | Investor Relations Contact | - | - |
Jeremy Stigall
PRN | Corporate Officer/Principal | 41 | 01/07/20 |
General Counsel | - | 05/04/21 | |
Sales & Marketing | - | 01/11/19 | |
General Counsel | - | - | |
Robert Korn
SAM | Sales & Marketing | 58 | 12/11/12 |
Chris Yelley
PRN | Corporate Officer/Principal | - | 01/01/12 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
B. Johnson
BRD | Director/Board Member | 72 | 01/09/19 |
Lynnette Fallon
BRD | Director/Board Member | 64 | 15/07/21 |
R. Fletcher
CHM | Chairman | 78 | 09/05/17 |
Pascal Girin
BRD | Director/Board Member | 64 | 03/09/14 |
Timothy Richards
BRD | Director/Board Member | 66 | 10/03/14 |
Joseph Burnett
CEO | Chief Executive Officer | 47 | 07/11/17 |
Matthew Klein
BRD | Director/Board Member | 52 | 16/04/20 |
Linda Liau
BRD | Director/Board Member | 57 | 02/11/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 27 069 568 | 25 012 797 ( 92,40 %) | 0 | 92,40 % |
Coordinate società
Clearpoint Neuro, Inc.
120 South Sierra Avenue Suite 100
92075, Solana Beach
+
http://www.clearpointneuro.comSettore
Vendite per attività
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-22,53% | 142 Mln | |
+8,07% | 219 Mrd | |
+6,59% | 183 Mrd | |
+11,26% | 133 Mrd | |
+26,57% | 108 Mrd | |
+0,65% | 63,06 Mrd | |
+13,35% | 52,02 Mrd | |
-0,62% | 48,2 Mrd | |
-0,93% | 40,37 Mrd | |
+11,54% | 39,35 Mrd |
- Borsa valori
- Azioni
- Azione CLPT
- Società ClearPoint Neuro, Inc.